Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

Author： Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.86, Iss.1, 2002-07, pp. : 57-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

By Chi D.S.   Venkatraman E.S.   Masson V.   Hoskins W.J.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A.   Nielsen D.   Engelholm S.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

The Relationship between Postoperative Decline of Serum CA 125 Levels and Size of Residual Disease after Initial Surgery in Patients with Advanced Ovarian Cancer: A CTF Study

By Gadducci A.   Landoni F.   Maggino T.   Sartori E.   Zola P.   Fanucchi A.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 234-237

Academic Press

Access to resources Recommend Favorite

Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By de Jong R.S.   Hofstra L.S.   Willemse P.H.B.   de Bruijn H.W.A.   de Vries E.G.E.   Boonstra H.   Mulder N.H.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite